Back | Next |
home / stock / elox / elox message board
Subject | By | Source | When |
---|---|---|---|
Fingers crossed! | RustyRyan09 | investorshub | 12/17/2021 11:23:36 PM |
$ELOX... .7387 close... .7105 bid here after hours... | The GidDy uP Kid | investorshub | 12/17/2021 10:49:32 PM |
Massive runup today on a nod from Oppenheimer | ok2buy | investorshub | 12/17/2021 9:02:55 PM |
Not sure what I am missing. Why the | upnorthvt | investorshub | 11/18/2021 2:27:09 PM |
What a haircut from $ELOX. And still | ok2buy | investorshub | 11/18/2021 1:38:17 PM |
Favourable results in their FDA clinical trial and | ok2buy | investorshub | 11/17/2021 3:25:13 PM |
$ELOX getting sucked down in a terrible market | ok2buy | investorshub | 07/14/2021 10:10:47 PM |
LOL......... ok Ill buy | NYC_JimBob | investorshub | 06/23/2021 2:05:02 PM |
Youll see $3 soon be patient you pathetic short | UndervaluedFortunes | investorshub | 06/23/2021 1:23:07 PM |
No movement on this....except down of course smh | NYC_JimBob | investorshub | 06/23/2021 12:39:33 PM |
$2.5M buy at close. Hmmm | 420man | investorshub | 06/20/2021 10:00:49 PM |
$$$$ | 420man | investorshub | 06/12/2021 8:53:47 PM |
znewcar1: ELOX 20% v5,0M c1.92 f86,1M H1.95 | znewcar1 | investorshangout | 06/03/2021 8:19:59 PM |
This thing should move this week | Fofo812 | investorshub | 05/19/2021 1:55:09 AM |
$$$ | 420man | investorshub | 05/18/2021 11:27:24 AM |
znewcar1: ELOX 30% v8,3M c3.94 f40,1M H6.77 S3.3 | znewcar1 | investorshangout | 12/17/2020 10:35:38 PM |
Goodness I butchered this trade at 3.7x | Awl416 | investorshub | 12/17/2020 6:14:20 PM |
Ha, here's my story... | tcm55 | investorshub | 09/05/2020 3:00:03 AM |
Top line data release. | noretreat | investorshub | 01/15/2020 1:30:48 PM |
Any news on this drop? | Carps | investorshub | 01/14/2020 9:28:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Eloxx Pharmaceuticals Inc. Company Name:
ELOX Stock Symbol:
NASDAQ Market:
Eloxx Pharmaceuticals Inc. Website:
First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations Positive written FDA feedback and guidance from a pre-Investigational New Drug Application (PI...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...